Journal of Veterinary Pharmacology and Therapeutics

Papers
(The median citation count of Journal of Veterinary Pharmacology and Therapeutics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Current review of isoxazoline ectoparasiticides used in veterinary medicine46
The challenges and applications of nanotechnology against bacterial resistance22
Pharmacokinetics of tolfenamic acid after different administration routes in geese (Anser cygnoides)16
Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part III: Sheep and goat15
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib14
Recent advances in microencapsulation of drugs for veterinary applications14
Canine and feline P‐glycoprotein deficiency: What we know and where we need to go12
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)12
Current review of hemp‐based medicines in dogs12
Pharmacokinetics and bioavailability of meloxicam in rainbow trout (Oncorhynchus mykiss) broodstock following intravascular, intramuscular, and oral administrations11
Pharmacokinetics of tolfenamic acid in goats after different administration routes11
Grapiprant: A snapshot of the current knowledge11
Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part II: Chicken and turkey11
Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)11
Pharmacokinetics of single and repeated oral doses of pregabalin oral solution formulation in cats10
Single dose and chronic oral administration of cannabigerol and cannabigerolic acid‐rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation10
Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus (Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling9
Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses9
Pour‐on administration of eprinomectin to lactating dairy goats: Pharmacokinetics and anthelmintic efficacy9
Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration9
In vitro and in vivo evaluation of a new phytotherapic blend to treat acute externa otitis in dogs9
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration8
Pharmacokinetics of robenacoxib following single intravenous, subcutaneous and oral administrations in Baladi goats (Capra hircus)8
Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses7
Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats7
Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine7
A review of current chemistry, pharmacology, and regulation of endogenous anabolic steroids testosterone, boldenone, and nandrolone in horses7
Equine antimicrobial therapy: Current and past issues facing practitioners7
Application of α2‐adrenergic agonists combined with anesthetics and their implication in pulmonary intravascular macrophages‐insulted pulmonary edema and hypoxemia in ruminants7
Applying metabolomics to veterinary pharmacology and therapeutics7
Pharmacokinetics of cefquinome in rainbow trout (Oncorhynchus mykiss) after intravascular, intraperitoneal, and oral administrations7
Pharmacokinetics of a single dose of Aficamten (CK‐274) on cardiac contractility in a A31PMYBPC3 hypertrophic cardiomyopathy cat model7
Effects of vatinoxan on xylazine‐induced pulmonary alterations in sheep6
Pharmacokinetics of paracetamol in the Thoroughbred horse following an oral multi‐dose administration6
Pharmacokinetics and bioavailability of solid dispersion formulation of tilmicosin in pigs6
The pharmacokinetic characteristics of sulfadiazine in channel catfish (Ictalurus punctatus) following oral and intravenous administrations6
Pharmacodynamics and plasma concentrations of dexmedetomidine with or without vatinoxan as a constant‐rate infusion in horses anaesthetized with isoflurane—A pilot study6
Pharmacokinetics of grapiprant and effects on TNF‐alpha concentrations following oral administration to horses5
Pharmacokinetic profiles of three dose rates of morphine sulfate following single intravenous, intramuscular, and subcutaneous administration in the goat5
Dosing protocols to increase the efficacy of butorphanol in dogs5
Pharmacokinetics of fluoxetine in horses following oral administration5
Antibacterial activity of combined aditoprim and sulfamethoxazole againstEscherichia colifrom swine and a dose regimen based on pharmacokinetic–pharmacodynamic modeling5
PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli5
Age‐related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep5
Oral and topical extra‐label administration of fipronil to laying hens: Assessment of the egg residue patterns5
Pharmacokinetics of meloxicam in laying hens after single intravenous, oral, and intramuscular administration5
Pharmacokinetics of a cytosine arabinoside subcutaneous protocol in dogs with meningoencephalomyelitis of unknown aetiology5
Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs5
Determination of the route of excretion of robenacoxib (Onsior™) in cats and dogs: A pilot study5
Doxycycline pharmacokinetics in geese5
Pharmacokinetics and pharmacodynamics of doxycycline in aStreptococcusequisubsp.zooepidemicusinfection model in horses5
Pharmacokinetics and bioavailability of danofloxacin in swan geese (Anser cygnoides) following intravenous, intramuscular, subcutaneous, and oral administrations4
Influence of Escherichia coli endotoxemia on danofloxacin pharmacokinetics in broilers following single oral administration4
Modulation of monepantel secretion into milk by soy isoflavones4
Pharmacokinetics of a sulfadiazine and trimethoprim suspension in neonatal foals4
Pharmacokinetics of oral and compounded intravenous gabapentin in Duroc swine (SusScrofa)4
Comparative pharmacokinetics of florfenicol in heifers after intramuscular and subcutaneous administration4
Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control4
Pharmacokinetic/pharmacodynamic modeling of ketoprofen and flunixin at piglet castration andtail‐docking4
Pharmacokinetics of danofloxacin after single oral and intravenous administration in non‐laying hens4
Determination of colistin in luminal and parietal intestinal matrices of chicken by ultra‐high‐performance liquid chromatography‐tandem mass spectrometry4
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygousMDR1‐deficient collie dogs4
Pharmacokinetics of ketorolac in juvenile loggerhead sea turtles (Caretta caretta) after a single intramuscular injection4
Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL‐31‐induced pruritus4
Single‐dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in cats4
Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ4
Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward3
Pharmacokinetics of dipyrone in horses: A multi‐dose, dose escalation study3
Metabolism and residue differences of Enrofloxacin between the brain and peripheral tissues and the resulting brain damages in crucian carp (Carassius auratus var. Pengze)3
PK/PD modelling of enrofloxacin againstGlaesserella parasuisinfection in pigs3
Assessment of verdinexor as a canine P‐glycoprotein substrate3
Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses3
Pharmacokinetics of a single dose of oclacitinib maleate as a top dress in adult horses3
Multidose pharmacokinetics and safety of a modified, compounded theophylline product in dogs3
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles3
Plasma disposition of ceftazidime in healthy neonatal foals following intravenous and intramuscular administration3
The plasma and tissue kinetics of sulfadiazine and its metabolite in Ictalurus punctatus after oral gavage at two temperatures3
Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety3
Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep3
Investigation of monensin Type A medicated article dissolution profiles in biorelevant media3
Pharmacokinetics of diphenhydramine following single‐dose intravenous and oral administration in non‐fasted adult horses3
Pharmacokinetics of furosemide in goats following intravenous, intramuscular, and subcutaneous administrations3
A novel transdermal ketoprofen formulation for analgesia in cattle3
Pharmacokinetics of tilmicosin in chicken joints based on a novel microdialysis sampling method3
Rational determination of cefazolin dosage regimen in horses based on pharmacokinetics/pharmacodynamics principles and Monte Carlo simulations3
Disposition kinetics of robenacoxib following intravenous and oral administration in geese (Anser anser domesticus)3
Pharmacokinetics of oral firocoxib in un‐weaned calves3
Pharmacokinetics and pulmonary distribution of Draxxin®(tulathromycin) in healthy adult horses3
Pharmacokinetics and pharmacodynamics of intravenous continuous rate infusion and repeated intramuscular administration of dexmedetomidine in standing horses3
Association of cytochrome P450 2D15 (CYP2D15) nonsynonymous polymorphisms and exon 3 deleted RNA splice variant with CYP2D15 protein content and enzyme function in dog liver microsomes3
Pharmacokinetic characteristics of danofloxacin in green sea (Chelonia mydas) and hawksbill sea (Eretmochelys imbricata) turtles3
Single‐dose pharmacokinetics of mycophenolic acid following administration of immediate‐release mycophenolate mofetil in healthy Beagle dogs3
Pseudomonas aeruginosasusceptibility, antibiogram and clinical interpretation, and antimicrobial prescribing behaviors for dogs with otitis in the Midwestern United States3
Pharmacokinetics, bioavailability, and tissue disposal profiles of Tiamulin fumarate in Nile tilapia (Oreochromis niloticus) following oral and intravenous administrations3
Pharmacokinetics of butorphanol in male neutered cats anesthetized with isoflurane3
Bayesian‐based withdrawal estimates using pharmacokinetic parameters for two capsaicinoid‐containing products administered to horses3
Cefovecin pharmacokinetics after single‐dose intramuscular administration in cheetahs (Acinonyx jubatus)3
Pharmacokinetic profiles of clarithromycin in freshwater crocodiles (Crocodylus siamensis)3
Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug–drug interactions involving canine cytochrome P‐450, UDP‐glucuronosyltransferase, and P‐glycoprotein3
Phenylbutazone pharmacokinetics in southern white rhinoceros (Ceratotherium simum simum) after oral administration2
In vivo joint synovial fluid disposition of a novel sustained‐release formulation of diclofenac and hyaluronic acid in horses2
Pharmacokinetic Profiles of Metamizole Metabolites after Intramuscular and Intravenous Administration in Healthy Arabian Horses2
Doxycycline serum protein binding in pigs reveals a relatively high free fraction2
Pharmacokinetic properties of tramadol and M1 metabolite in Northeast Brazilian donkeys (Equus asinus)2
Safety of torasemide in healthy adult dogs administered daily for 26 weeks2
Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis2
Examination of the pharmacokinetics and differential inhibition of cyclooxygenase isoenzymes in New Zealand white rabbits (Oryctolagus cuniculus) by the Non‐Steroidal anti‐inflammato2
Can diarrhea affect the pharmacokinetics of racecadotril in neonatal calves?2
Pharmacokinetics of danofloxacin in freshwater crocodiles (Crocodylus siamensis) after intramuscular injection2
Pharmacokinetics of single dose oral Terbinafine in common shelducks (Tadorna tadorna)2
Safety and immunogenicity of an adjuvanted recombinant spike protein‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine, SpikeVet™, in selected Carnivora,2
Pharmacokinetics and pharmacodynamics of oral and intravenous metoprolol tartrate in clinically healthy horses2
Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus)2
Pharmacokinetics and effects of codeine in combination with acetaminophen on thermal nociception in horses2
Oral pharmacokinetic profile of fipronil and efficacy against flea and tick in dogs2
Control of ticks on horses using abamectin‐impregnated ear tags. A pharmacokinetic and pharmacodynamic study2
Characterization of P‐glycoprotein orthologs from human, sheep, pig, dog, and cat2
Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial2
The effect of doxapram on survival and APGAR score in newborn puppies delivered by elective caesarean: A randomized controlled trial2
Effects of acaricides on the activities of monooxygenases in bovine liver microsomes2
Pharmacokinetic profile of a single dose of an oral pradofloxacin suspension administered to eastern long‐necked turtles (Chelodina longicollis)2
Ivermectin induces chicken BCRP/ABCG2 expression and function: Involvement of CXR signaling pathway and mRNA stabilization2
Pharmacokinetics of maropitant citrate in Rhode Island Red chickens (Gallus gallus domesticus) following subcutaneous administration2
Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea2
Anticoagulant profile of subcutaneous enoxaparin in healthy dogs2
Pharmacokinetics and bioavailability of carprofen in sheep2
Pharmacokinetics and pharmacodynamics of intravenous and oral apixaban in horses2
Pharmacokinetics and bioavailability of furosemide in sheep2
Effect of ketoprofen on intravenous pharmacokinetics of ganciclovir in chukar partridges (Alectoris chukar)2
Selective inhibition of cyclooxygenase‐2 by enflicoxib, its enantiomers and its main metabolites in vitro in canine blood2
Development and application of a physiologically based pharmacokinetic model for orbifloxacin in crucian carp (Carassius auratus)2
Co‐formulation of ketoprofen with tulathromycin alters pharmacokinetic and pharmacodynamic profile of ketoprofen in cattle2
The future of veterinary pharmacology education; veterinary educators in pharmacology: A new special interest group2
A pilot study comparing the pharmacokinetics of injectable cyanocobalamin and hydroxocobalamin associated with a trace mineral injection in cattle2
Pharmacokinetics and milk excretion pattern of eprinomectin at different dose rates in dairy cattle2
Potential interactions between an oral fosfomycin formulation and feed or drinking water: Impact on bioavailability in piglets2
Plasma and urine pharmacokinetics of two formulations of dexamethasone in greyhound dogs2
O111 | Population PK modeling of different sulfonamides in association with trimethoprim in pigs1
Comparative disposition kinetics of oral deracoxib in sheep and goats1
Pharmacokinetics of toltrazuril and its metabolite, toltrazuril sulfone, in suckling piglets following oral and intramuscular administrations1
P19 | Determination of optimal ratios for three sulfonamides/trimethoprim combinations against E. coli using checkerboard and time‐kill assays1
Pharmacokinetics and pharmacokinetic interactions of orally administered oxfendazole and oxyclozanide tablet formulation to sheep1
Sodium‐glucose transport protein 2 inhibitor use in the management of insulin dysregulation in ponies and horses1
Enrofloxacin pharmacokinetics in yellow catfish (Pelteobagrus fulvidraco): A comparative analysis of oral, intramuscular, and bath administration1
Pharmacokinetics and residue elimination of norfloxacin in rainbow trout (Oncorhynchus mykiss)1
Therapeutic efficacy of enrofloxacin in treatment of Francisella orientalis infections in juvenile Nile tilapia (Oreochromis niloticus L.)1
Oral cinacalcet administration decreases serum ionized calcium and parathyroid hormone concentrations in healthy dogs1
The publication of studies involving the use of human critically important antimicrobial agents in veterinary species1
Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats1
Comparison of oral, nebulized and combination antibiotic treatment ofBordetellabronchisepticain baboons (Papiospp.)1
In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) – A preliminary study1
Pharmacokinetics of thiamine (vitamin B1) in adult horses after administration of three single intravenous doses1
Florfenicol urinary excretion and its potential for treating canine urinary tract infections1
Pharmacokinetics and pharmacodynamics of dextroketamine alone or combined with midazolam in Caiman crocodilus1
Pharmacokinetics of levofloxacin mesylate in healthy adult giant panda after single‐dose administration via different routes1
Metronidazole pharmacokinetics in geese (Anser anser domesticus) after intravenous and oral administrations1
Plasma concentrations of diclazuril following oral administration of diclazuril and diclazuril sodium salt to cattle1
Multicentered masked placebo‐controlled phase 3 clinical study of an extended duration transdermal buprenorphine solution for post‐operative pain in cats1
Depletion of tilmicosin residue in Gushi chickens following oral administration via drinking water1
Cebranopadol, a novel first‐in‐class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits1
Diagnostic clinical microbiology1
Pharmacokinetics of oral tapentadol in cats1
Pharmacokinetics and therapeutic efficacies of fenbendazole in comparison with levamisole in helminth‐infected Caspian turtles (Mauremys caspica)1
Therapeutics of managing reduced red cell mass associated with chronic kidney disease – Is there a case for earlier intervention?1
Pharmacokinetics of aminocaproic acid in thoroughbred horses1
Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog1
The pharmacokinetics of single oral dose extended‐release topiramate and adverse effects after multi‐dose administration in healthy cats1
Evaluation of partial area under the curve in bioequivalence studies using destructive sampling design1
Pharmacokinetic profile and effect on the faecal microbiome of a single dose of pradofloxacin oral suspension in the rabbit(Oryctolagus cuniculus)1
Pharmacokinetic report: Pharmacokinetics of a single oral dose of gabapentin in goats (Capra hircus)1
Pharmacokinetics of doxycycline hyclate in pigs with a new feed premix formulation1
Urinary cortisol metabolites are reduced in MDR1 mutant dogs in a pilot targeted GC‐MS urinary steroid hormone metabolome analysis1
Plasma pharmacokinetics, pulmonary disposition, and safety of subcutaneous gamithromycin in alpacas1
Pharmacokinetics of carprofen following single and repeated intravenous administrations of different doses in sheep1
Preliminary bioequivalence of an oral integrating film formulation containing meloxicam with a suspension formulation in beagle dogs1
Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus)1
Multicentered masked placebo‐controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in cats1
Pharmacokinetic evaluation of oral deracoxib in geese (Anser anser domesticus)1
O103 | The effect of canagliflozin on blood glucose and insulin in healthy standardbred horses1
The history and pharmacology of buprenorphine: New advances in cats1
Novel holistic pharmacokinetic model applied to plasma and urine concentrations of 2,5‐dihydroxybenzene sulphonate following administrations of calcium dobesilate and etamsylate to exercised horses1
A narrative review of the phenomenon of predatory journals to create awareness among researchers in veterinary medicine1
A validated UPLC‐MS/MS method for quantification of glutamine in plasma and pharmacokinetic study of oral glutamine tablets in healthy Beagles1
Plasma and urine pharmacokinetics of hydroxyzine and cetirizine following repeated oral administrations to exercised horses1
Pharmacokinetic characteristics of azithromycin in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at three different dosages1
O49 | Characterization of the immune landscape of canine and feline mammary tumors as a basis for candidate biomarker, drug and toxicity studies1
Pharmacokinetics of glaucine after intravenous and oral administrations and detection of systemic aporphine alkaloids after ingestion of tulip poplar shavings in horses1
Pharmacokinetics of doxycycline in dogs1
Pharmacokinetic properties of abamectin after oral administration in dogs1
Pharmacokinetics of orally administered single‐dose ponazuril in cats1
Pharmacokinetics of tilmicosin in plasma, urine and feces after a single intragastric administration in donkey (Equus asinus)0
O59 | Breakthrough: A first‐in‐class virtual simulator for dose optimization of ACE inhibitors in veterinary cardiology0
O82 | Homogeneity, stability, interactions, and cross‐contamination of antibacterial drugs mixed into drinking water for group treatment in broilers0
O91 | Pharmacokinetics and therapeutic efficacy of liposomal cannabidiol (CBD) injection: A pilot clinical study in dogs with naturally‐occurring osteoarthritis0
O64 | PK/PD based dose optimization of enrofloxacin in combination with sulfamethoxazole/ trimethoprim against Pasteurella multocida in pigs0
Depletion of dexamethasone in cattle: Food safety study in dairy and beef cattle0
P35 | The pharmacokinetics of gallic acid in finisher broilers0
O67 | Differences between global, European, and Dutch categorization of antibiotics for veterinary use: What would be the consequences of alignment?0
Effects of starvation on the pharmacokinetics and optimal dosages of florfenicol and associated serum biochemistry in Asian seabass (Lates calcarifer)0
P79 | Development of analytical method for veterinary drugs in honey using LCMS/MS and GCMS/MS0
P12 | Antibacterial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis isolated from pigs in Hungary, 2018–20210
Doxycycline pharmacokinetics and tissue depletion in striped catfish (Pagasianodon hypophthalmus) after oral administration0
O79 | Toxicity of individual and binary mixtures of perfluoroalkyl compounds in freshwater algae Raphidocelis subcapitata0
Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii)0
O41 | Regenerative medicine for the treatment of pharmacoresistant epilepsy?0
Pharmacokinetics of meloxicam following intravenous administration at different doses in sheep0
I19 | Ghent University's Veterinary Oncology Network: Towards solutions for human and veterinary cancer patients0
0
Issue Information0
I2 | The availability and use of antimicrobial agents0
Corrigendum0
Introduction0
O39 | Effects of flunixin meglumine on the systemic inflammatory response to intravenous lipopolysaccharide in horses0
O108 | Red orange and lemon extract ameliorates the renal toxicity effect induced by Ochratoxin A through the modulation of ROS accumulation and NF‐kB signaling0
I17 | Gene editing and gene therapy: Perspectives for the future of veterinary medicine in the ‘CRISPR era’0
Response to Letter to the Editor regarding ‘Pharmacokinetics of ceftiofur sodium in Peekapoo dogs following a single intravenous and subcutaneous injection’0
I29 | The global problem of pharmaceutical pollution0
Using simulations to explore the potential effect of disease and inflammation on the frequency of violative flunixin residues in cattle0
O20 | The effect of ATR kinase inhibition on chlorambucil activity against canine lymphoma and leukemia cell lines0
O85 | Antibacterial activity of propyl gallate in combination with orbifloxacinagainst E. coli in an in vitro pharmacodynamic model0
Potential for extending the chloramphenicol dosing interval for canine urinary tract infections0
P11 | Synovial and systemic pharmacokinetics of florfenicol in pigs0
Detection and Analysis of Florfenicol Residues and Metabolites in Nile Tilapia (Oreochromis niloticus) Tissues Post‐Oral Administration in Tropical Waters0
O26 | PK/PD informed dosage regimen for antimicrobial prophylaxis in companion animal surgery: From proof of concept to pipeline0
Detection times of clodronic acid in horses with orthopedic disease0
O71 | Pharmacokinetics of macrocyclic lactones endectocide in indigenous zebu cattle and its insecticidal efficacy on Anopheles arabiensis0
Folke Rasmussen: An appreciation0
P82 | Multiclass screening method to detect banned substances in urine by LCMS/MS0
Issue Information0
0
P44 | Antimicrobial activity of essential oils extracted from Origanum vulgare and Melaleuca armillaris against Escherichia coli isolated from poultry feces0
Issue Information0
O58 | A versatile extraction and purification method for ivermectin detection through HPLC and LC/MS in feed, water, feces, soil, and sewage0
P83 | Limits of the limits in the food and feed safety0
Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration0
O96 | The use of zinc‐chloride coated splints in biofilm prevention following septoplasty0
Margin of safety of extended‐duration transdermal buprenorphine solution following multiple‐dose administrations to cats0
Author Index0
Oral fluconazole has variable pharmacokinetics in dogs0
I6 | Biosecurity in animal production to improve health and reduce antimicrobial use0
P42 | Teat dip disinfectant formulation for dairy cows based on Melaleuca armillaris essential oil0
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?0
P9 | Pharmacokinetics of lincomycin in laying hens and its residue profiles in egg and plasma0
Erratum0
P14 | Antibiofilm effect of plant extracts0
Pharmacokinetics of oral clonazepam in growing commercial pigs (Sus scrofa domestica)0
O52 | RNAseq characterization of transcriptional biomarkers related to testosterone esters administration in fattening pigs0
Letter to the Editor regarding “The publication of studies involving the use of human critically important antimicrobial agents in veterinary species”0
P87 | Antibacterial drug residues in animal tissues for human consumption: Monitoring and exposure assessment0
Letter to the Editor regarding ‘The publication of studies involving the use of human critically important antimicrobial agents in veterinary species’0
0.095016002655029